Abstract
Background - Inflammation (assessed by C-reactive protein [CRP]) and the metabolic syndrome (MetS) are associated with cardiovascular disease (CVD), but population-based data are limited. Methods and Results - We assessed the cross-sectional relations of CRP to the MetS (National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Adult Treatment Panel III definition) in 3037 subjects (1681 women; mean age, 54 years) and the utility of CRP and the MetS to predict new CVD events (n=189) over 7 years. MetS (≥3 of 5 traits) was present in 24% of subjects; mean age-adjusted CRP levels for those with 0, 1, 2, 3, 4, or 5 MetS traits were 2.2, 3.5, 4.2, 6.0, or 6.6 mg/L, respectively (P trend
Original language | English |
---|---|
Pages (from-to) | 380-385 |
Number of pages | 5 |
Journal | Circulation |
Volume | 110 |
Issue number | 4 |
DOIs | |
Publication status | Published - 27 Jul 2004 |
Keywords
- C-reactive protein
- Cardiovascular diseases
- Insulin
- Prognosis
- Risk factors